Xiao Jinzhang, Wang Qiuhong, Yang Qichang, Wang Hua, Qiang Fulin, He Song, Cai Jin, Yang Lei, Wang Yingying
Department of Internal Oncology Medicine, Affiliated Nantong Cancer Hospital, Nantong University, Nantong, Jiangsu 226000, P.R. China.
The Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, Jiangsu 226000, P.R. China.
Oncol Lett. 2018 Apr;15(4):4745-4752. doi: 10.3892/ol.2018.7930. Epub 2018 Feb 2.
Gastric cancer is one of the most common types of malignancy worldwide. However, the molecular mechanisms of cancer development remain unclear. Src-associated in mitosis of 68 kDa (Sam68) is involved in cell proliferation, transformation, tumorigenesis and metastasis in several types of cancer. The present study aimed to assess the expression and function of Sam68 in human gastric cancer. Western blot analysis and immunohistochemistry indicated that Sam68 expression was increased in tumor samples and the levels were associated with the grade of malignancy. High Sam68 expression was associated with the poor prognosis of patients with gastric cancer. , following knockdown of Sam68 by transfection of gastric cancer cells with small interfering RNA, the cell viability, cell cycle progress, migration and invasion were decreased. The results of the present study revealed that Sam68 may be a novel prognostic factor for, and is associated with cell growth, migration and invasion in, gastric cancer.
胃癌是全球最常见的恶性肿瘤类型之一。然而,癌症发生发展的分子机制仍不清楚。68 kDa有丝分裂相关的Src蛋白(Sam68)参与多种类型癌症的细胞增殖、转化、肿瘤发生和转移。本研究旨在评估Sam68在人胃癌中的表达及功能。蛋白质印迹分析和免疫组织化学表明,Sam68在肿瘤样本中的表达增加,且其水平与恶性程度相关。Sam68高表达与胃癌患者的不良预后相关。在用小干扰RNA转染胃癌细胞敲低Sam68后,细胞活力、细胞周期进程、迁移和侵袭能力均降低。本研究结果表明,Sam68可能是胃癌的一种新的预后因子,且与胃癌细胞的生长、迁移和侵袭有关。